Navigation Links
Genedata Biologics 3.0 Boosts Efficiency Through Standardization
Date:1/21/2013

Palm Springs, Calif. (PRWEB) January 21, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the release of Genedata Biologics™ 3.0, the latest version of its enterprise solution for biologics R&D. A first-in-class software solution for integrated data management, Genedata Biologics enables R&D organizations to more efficiently discover and develop novel biotherapeutics. Version 3.0 dramatically improves process efficiency with new functionality for standardization of antibody screening, protein engineering, and protein production processes. Genedata will present the latest features of its platform during the Antibodies for the 21st Century track at PepTalk 2013 (Renaissance Hotel; January 21 – 25).

Standardization – The Strategic Advantage for Innovative R&D in Biotherapeutics

Workflow and nomenclature standardization are key success factors for large-scale biopharma discovery operations, which consist of specialized groups working in division-of-labor environments across departments and sites, as well as with numerous external partners and CROs. A scalable data management platform shared among all stakeholders and directly interfacing with laboratory automation equipment is required to facilitate the frequent handover and processing of candidate molecules, samples, and testing results.

“Standardization is a strategic advantage in today’s biopharma R&D. The new version of Genedata Biologics provides a complete view on all biologic
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Genedata Screener to Present at 10th Annual Ion Channel Retreat
2. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
3. Genedata Screener for HCS Advances Phenotypic Screening
4. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
5. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
6. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
7. Pinnacle Biologics, Inc. Announces the Successful Completion of a Financing Round
8. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
9. Adeona Becomes Synthetic Biologics, Inc.
10. Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
11. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Calif. , July 24, 2014  ECC West ... Denver, Colorado with University College Hospital (UCH) ... a development project to finance, design, construct, and operate ... Nigeria . Under the first of ... prepare scoping documents and funding applications. UCH Ibadan intends ...
(Date:7/24/2014)... of Engineering at the University of Delaware, is ... in energy engineering, environmental sustainability and electronics. , ... rock with a well-defined, crystalline structure. At the ... decided that zeolites can separate molecules with size ... (one-tenth of a nanometer), making them useful to ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Your ... advances in modeling lithium-ion battery storage capacity. , ... from a theoretical model created at Lawrence ... that predicts how carbon components will perform ... storage emphasizes the urgent need for higher-performance batteries. ...
(Date:7/24/2014)... 24, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Sulphate basic information, including its definition, classification, ... This research covers the international market analysis, including ... analysis covering macroeconomic environment & economic situation analysis, ...
Breaking Biology Technology:ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2University of Delaware researcher describes new approach for creating organic zeolites 2Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... HARBIN, China, Feb. 24 /PRNewswire-Asia-FirstCall/ -- China ... or "the Company") (Nasdaq: CSKI ... over-the-counter,drugs in the People,s Republic of China ... Peng Lai Jin Chuang Pharmaceutical Company ("Jin,Chuang"), ...
... biotech company in Madison, Wisconsin is so concerned about ... that they have volunteered to give away free bottles ... the incoming administration who has forgotten to pay taxes ... government employees in positions of responsibility have many important ...
... -- Quarter Highlighted by Cinryze(TM) [C1 Inhibitor (human)] Commercial Launch ... VPHM ) reported today its financial results for the fourth ... 30, 2008 include:Operational: , , , ... Lev Pharmaceuticals, Inc. (Lev) in October 2008; , ...
Cached Biology Technology:China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 3Mental Stimulus Package: Government Officials who Forgot to Pay Taxes Will Receive Free Memory-boosting Supplement 2Mental Stimulus Package: Government Officials who Forgot to Pay Taxes Will Receive Free Memory-boosting Supplement 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 12
(Date:7/25/2014)... congenital central nervous system disease that is caused ... during the embryonic phase. Many patients have varying ... neurocognitive retardation. Such problems decrease the patients, functional ... Ankara Physical Medicine and Rehabilitation Education and Research ... with SB, using the Pediatric Evaluation of Disability ...
(Date:7/25/2014)... time, Spanish researchers have detected an unknown interaction between ... are introduced into a droplet of salt water and ... crystallisation to create biomineralogical biosaline 3D morphologically complex formations, ... bacteria are revived. The discovery was made by chance ... of the Astrobiology journal and may help ...
(Date:7/24/2014)... SAN DIEGO , July 24, 2014 /PRNewswire-iReach/ -- ... managing data from cardiac devices, has cut emergency room ... the UC San Diego (UCSD) Medical Center, according to ... Journal. The UCSD Emergency Departments are using the suite ... such as pacemakers or defibrillators. "Using Geneva,s ...
Breaking Biology News(10 mins):Bacteria manipulate salt to build shelters to hibernate 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
... Georgian town of Reepham in Norfolk are taking part in ... Anglia (UEA). Like two million homes across the ... warmth and hot water, and the aim of the UEA ... a viable option. The renewable fuel being used is ...
... a striking similarity between heart disease and Duchenne muscular ... that a new class of experimental drugs for heart ... At first glance, heart failure and the muscle-wasting ... usually before the age of 6, destroying their muscle ...
... GAITHERSBURG, Md.The bacterium behind one of mankind,s deadliest scourges, ... Institute of Standards and Technology (NIST) and the Department ... answering the decades-old question of what controls the switching ... of life,s functions. In a Journal of ...
Cached Biology News:Trailblazing rural community shows green heating oil a viable option 2While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy 2Long-sought protein structure may help reveal how 'gene switch' works 2Long-sought protein structure may help reveal how 'gene switch' works 3
Mouse anti human pro-Relaxin-2...
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... polyclonal to ErbB 2 - BSA ... for all tested applications). ... conjugated to KLH, corresponding to C ... c-ErbB2 Entrez GeneID: ...
Anti human PPAR gamma2 mouse monoclonal antibody...
Biology Products: